Which monoclonal antibody would work with omic... - CLL Support

CLL Support

22,529 members38,700 posts

Which monoclonal antibody would work with omicron covid 19?

lankisterguy profile image
lankisterguyVolunteer
12 Replies

Which monoclonal antibody would work with omicron covid 19?

Reposted from CLLSLL@groups.io : groups.io/g/CLLSLL/message/...

with permission from the author

-

From: Rick Furman Date: Sat, 18 Dec 2021 19:29:29 EST

Right now, the majority of variants isolated in the US are still delta. All we know is that REGEN-COV and bamlanivimab-etesevimab have diminished activity against omicron and sotrovimab and Evusheld retains its neutralizing activity. Interestingly, the FDA has updated the Evusheld approval to require sequencing of all breakthrough cases of Evusheld to generate these data.

For now, it is important to just move forward with the same precautions and avoid getting infected. If infected or exposed, I would recommend receiving an antibody cocktail. Which one available will be dependent upon distribution and availability.

Fortunately, the Pfizer pill, Paxlovid, should be effective against all variants given its targeting of an internal enzyme.

Rick Furman

-

Len

Written by
lankisterguy profile image
lankisterguy
Volunteer
To view profiles and participate in discussions please or .
Read more about...
12 Replies
neurodervish profile image
neurodervish

Thanks Len!

db601 profile image
db601

Len, thank you for this post.

KatieBlue profile image
KatieBlue

GSK is supposed to still be effective against omicron. Regeneron and Eli Lilly versions, as noted above, not so much. Evusheld seems to be effective, and while approved for immuno compromised, is not yet available…

bennevisplace profile image
bennevisplace

Thanks Len. I think the claims for GSK-Vir's Sotrovimab (Xevudy) and Astrazeneca's Evusheld need to be tested in the real world before we know how well they neutralise Omicron.

UK members will be pleased to know that Xevudy is now available on the NHS, or so it was announced this morning. From memory, the government has purchased 100,000 doses, to add to the 480,000 of Ronapreve. We're still waiting for Evusheld to be approved by the medicines regulator.

lankisterguy profile image
lankisterguyVolunteer in reply to bennevisplace

I agree that it would be better to have more detailed data, but likely by the time we get enough data, the virus will have evolved several times, so experts providing informed guesses is the best we can do for now.

Len

bennevisplace profile image
bennevisplace

Yes, it's just that most of the experts concerned were evaluating their own drug: Regeneron, GSK and AZ, Even the German researchers, who found the most Omicron-neutralising monoclonals to be Sotrovimab and DZIF-10c, stated competing interests:

H.G., K.V., and F.Kl. are listed as inventors on pending patent application(s) on SARS-CoV-2-neutralizing antibodies filed by the University of Cologne medrxiv.org/content/10.1101... The patents being for DZIF-10c, which is in clinical trials.

neurodervish profile image
neurodervish

This Forbes article titled How Omicron Evades Natural Immunity, Vaccination, And Monoclonal Antibody Treatments (shared by KatieBlue ) says, "Of the eight approved or authorized antibodies, all but sotrovimab completely or almost completely lost their neutralizing activity against the Omicron pseudovirus. A cocktail of cilgavimab and tixagevimab had a reduced potency of 200-fold. Sotrovimab, conversely, shows a drop of 3-fold drop in neutralization potency." forbes.com/sites/williamhas...

Cilgavimab and tixagevimab are the mAbs in Evusheld. I've been pinning my hopes on Evusheld, so... not sure what to think now.

avzuclav profile image
avzuclav

lankisterguy did you see the FDA docs for Paxlovid? It says to avoid use of venetoclax and ibrutinib.

fda.gov/media/155050/download

Paxlovid - ibrutinib and venetoclax
lankisterguy profile image
lankisterguyVolunteer in reply to avzuclav

Thanks for posting that info. -

I just learned of the conflict this morning when my CLL expert Dr. Furman responded to a similar concern on CLLSLLgroups.io groups.io/g/CLLSLL/message/...

Re: Paxlovid Pill Approved for COVID 19 Treatment ... But check the Contraindications- Ibrutinib and Venetoclax

From: Rick Furman

Date: Wed, 22 Dec 2021 21:45:37 EST

Paxlovid is a CYP3A inhibitor and will impair clearance of many drugs. This would include all drugs with the "grapefruit" warning. Given the course is only five days, holding the agent is often all that is necessary, but dose reductions, etc. would also work.

Rick Furman

(reposted here with permission from Dr. Furman)

-

I have printed a copy and clipped it to my CLL Society COVID-19 Action Plan documents cllsociety.org/covid-19/ and alerted my wife that we will confer with Dr. Furman for a dose adjustment or pause of Venetoclax for 5 days if I need to take Paxlovid at any time in the future.

-

Len

Justasheet1 profile image
Justasheet1 in reply to lankisterguy

Len,

Can you repost this as this is important to see.

Jeff

Justasheet1 profile image
Justasheet1

Good catch Avz. Just when I saw a glimmer….. ☹️

skipro profile image
skipro

Bebteluvomab works against Omicron

You may also like...

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

A study featuring monoclonal antibody treatments (mAbs) Sotrovimab, Evusheld et al, and antiviral...

Monoclonal antibodies vs. Paxlovid

received the full recommended doses of Evusheld since antibody tests showed I had an inadequate...

How reliable are covid-19 lateral flow tests for detecting omicron?

detecting the Omicron variant of the SARS-COV2 virus as they are at detecting Delta and earlier...

Omicron variant, antibodies, T-cells

able to neutralise the Omicron variant. - Booster vaccinations can increase antibody levels to the...

The more symptoms the better? Covid-19 vaccine side effects and long-term neutralizing antibody

have been made aware today due to a post on CLLSLL@ Groups.io. Both studies show a positive...